Gene: CDKN2B-AS1 ×
Source: GWASDB ×
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs4977756
rs4977756
CDKN2B-AS1
G 0.900 GeneticVariation GWASDB Genome-wide association study of glioma and meta-analysis. 22886559

2012
dbSNP: rs4977756
rs4977756
CDKN2B-AS1
0.900 GeneticVariation GWASDB Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs4977756
rs4977756
CDKN2B-AS1
G 0.900 GeneticVariation GWASDB We identified five risk loci for glioma at 5p15.33 (rs2736100, TERT; P = 1.50 x 10(-17)), 8q24.21 (rs4295627, CCDC26; P = 2.34 x 10(-18)), 9p21.3 (rs4977756, CDKN2A-CDKN2B; P = 7.24 x 10(-15)), 20q13.33 (rs6010620, RTEL1; P = 2.52 x 10(-12)) and 11q23.3 (rs498872, PHLDB1; P = 1.07 x 10(-8)). 19578367

2009
dbSNP: rs2157719
rs2157719
CDKN2B-AS1
0.820 GeneticVariation GWASDB Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs2157719
rs2157719
CDKN2B-AS1
0.820 GeneticVariation GWASDB Genome-wide association study identifies five susceptibility loci for glioma. 19578367

2009
dbSNP: rs1412829
rs1412829
CDKN2B-AS1
0.810 GeneticVariation GWASDB Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs1412829
rs1412829
CDKN2B-AS1
0.810 GeneticVariation GWASDB Genome-wide association study identifies five susceptibility loci for glioma. 19578367

2009
dbSNP: rs1412829
rs1412829
CDKN2B-AS1
C 0.810 GeneticVariation GWASDB Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. 19578366

2009
dbSNP: rs1063192
rs1063192
CDKN2B ; CDKN2B-AS1
0.710 GeneticVariation GWASDB Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs2151280
rs2151280
CDKN2B-AS1
0.710 GeneticVariation GWASDB Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs1063192
rs1063192
CDKN2B ; CDKN2B-AS1
0.710 GeneticVariation GWASDB Genome-wide association study identifies five susceptibility loci for glioma. 19578367

2009
dbSNP: rs10116277
rs10116277
CDKN2B-AS1
0.700 GeneticVariation GWASDB Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs10120688
rs10120688
CDKN2B-AS1
0.700 GeneticVariation GWASDB Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs1412832
rs1412832
CDKN2B-AS1
0.700 GeneticVariation GWASDB Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs1537375
rs1537375
CDKN2B-AS1
0.700 GeneticVariation GWASDB Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs2383207
rs2383207
CDKN2B-AS1
0.700 GeneticVariation GWASDB Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs3217992
rs3217992
CDKN2B ; CDKN2B-AS1
0.700 GeneticVariation GWASDB Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs4977574
rs4977574
CDKN2B-AS1
0.700 GeneticVariation GWASDB Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs573687
rs573687
CDKN2B-AS1
0.700 GeneticVariation GWASDB Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs7049105
rs7049105
CDKN2B-AS1
0.700 GeneticVariation GWASDB Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011
dbSNP: rs944797
rs944797
CDKN2B-AS1
0.700 GeneticVariation GWASDB Chromosome 7p11.2 (EGFR) variation influences glioma risk. 21531791

2011